BlackRock’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $271M | Sell |
|
|||||
|
2025
Q2 | $308M | Sell |
|
|||||
|
2025
Q1 | $253M | Buy |
|
|||||
|
2024
Q4 | $165M | Buy |
|
|||||
|
2024
Q3 | $165M | Buy |
|
|||||
|
2024
Q2 | $131M | Buy |
|
|||||
|
2024
Q1 | $124M | Buy |
|
|||||
|
2023
Q4 | $97.6M | Buy |
|
|||||
|
2023
Q3 | $201M | Buy |
|
|||||
|
2023
Q2 | $155M | Buy |
|
|||||
|
2023
Q1 | $106M | Buy |
|
|||||
|
2022
Q4 | $151M | Buy |
|
|||||
|
2022
Q3 | $79.9M | Buy |
|
|||||
|
2022
Q2 | $19.8M | Buy |
|
|||||
|
2022
Q1 | $26.9M | Sell |
|
|||||
|
2021
Q4 | $41.1M | Buy |
|
|||||
|
2021
Q3 | $41.7M | Buy |
|
|||||
|
2021
Q2 | $45.8M | Buy |
|
|||||
|
2021
Q1 | $42.5M | Buy |
|
|||||
|
2020
Q4 | $34.8M | Sell |
|
|||||
|
2020
Q3 | $41.7M | Buy |
|
|||||
|
2020
Q2 | $25.7M | Buy |
|
|||||
|
2020
Q1 | $15.3M | Buy |
|
|||||
|
2019
Q4 | $12M | Buy |
|
|||||
|
2019
Q3 | $7M | Buy |
|
|||||
|
2019
Q2 | $2.8M | Buy |
|